Mechanisms of Growth Inhibition by Helicobacter Pylor
Mechanisms of Growth Inhibition by Helicobacter Pylor
批准号:
6524466
负责人:
Hassan Ashktorab
金额:
$7.55万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2004-11-30
中文摘要
描述(由申请人提供):
发现H.幽门螺杆菌是一个重要因素的发展,
消化性溃疡已经极大地改变了溃疡患者的治疗方式。
溃疡愈合速度更快的人治疗抗生素除了酸
药对这一观察结果的一种可能解释是,
H.幽门;因此,溃疡愈合速度更快,
H的缺失。幽门感染流行病学研究强烈表明,
相关H. pylori与胃癌的关系这些数据使世界
卫生组织指定H。pylori是I类致癌物。有人认为
至少有一半的胃癌是由于感染了这种
细菌。然而,很少有人知道H。幽门螺杆菌可能直接
影响胃细胞导致胃癌。流行病学数据支持
这种细菌作为辅因子,因为它会导致慢性胃炎,
进展为萎缩性胃炎,肠型胃癌的前驱病变
癌
然而,这种细菌也与弥漫性胃癌密切相关,
发生在其他正常(非萎缩性)胃粘膜中,其中细菌
在癌症发生时就存在感染。体内研究表明,
一些细菌菌株在没有升高的情况下引起显著的细胞损伤
在胃细胞凋亡中的作用一种解释是,这种细菌在引起细胞凋亡的同时,
损伤,能够下调细胞凋亡。细胞凋亡的减少,
受损的胃细胞是这种细菌可能
直接增加胃细胞对致癌物质的易感性
转换.该基金旨在评估H的直接影响。幽门
胃上皮细胞的细胞死亡。本项目的具体目标
目的:1)进一步阐明p53通路在H.幽门
通过测定细胞中p53的磷酸化程度诱导细胞凋亡
暴露于H.幽门螺杆菌菌株和磷酸化的重要性,
丝氨酸-15、-20和-46在细胞凋亡方面。此外,为了评估p53
在不存在H的情况下,响应于ROS种类的磷酸化。幽门螺杆菌和
H.幽门螺杆菌和抗氧化剂。2)确定参与和
通过磷酸化激活p53 AIP 1的意义
p53丝氨酸-46。细菌暴露对胃上皮细胞的作用机制
关于p53还没有研究细胞死亡。这些研究很重要
为了阐明特定的p53通路,
细菌,导致调节细胞死亡。
特别是,无论是否刺激活性氧(ROS)的H。
pylori是p53磷酸化导致细胞凋亡所必需的。这些研究
这将有助于确定细菌如何可能通过
ROS的产生,在特定情况下,这可能会改变一个人的风险,
发展成癌症
英文摘要
DESCRIPTION (provided by applicant):
The discovery that H. pylori is an important factor in the development of
peptic ulcers has dramatically changed the way ulcer patients are treated.
Ulcers heal faster in persons treated with antibiotics in addition to acid
medication. One possible explanation for this observation is that cell
generation is impaired by H. pylori; thus, ulcer healing occurs more rapidly in
the absence of H. pylori infection. Epidemiological studies have strongly
associated H. pylori with gastric carcinogenesis. These data led the World
Health Organization to designate H. pylori a Class I carcinogen. It is felt
that at least half of all gastric cancers are attributed to infection with this
bacterium. However, there is little known as to how H. pylori may directly
effect gastric cells to cause gastric cancer. Epidemiological data supports
this bacterium as a cofactor because it causes chronic gastritis which may
progress to atrophic gastritis, a precursor lesion for intestinal type gastric
cancer.
However, this bacterium is also strongly linked to diffuse gastric cancer which
occurs in otherwise normal (non-atrophic) gastric mucosa, where the bacterial
infection is present at the time the cancer occurs. In vivo studies show that
some bacterial strains cause significant cell injury in the absence of a rise
in gastric apoptosis. One explanation is that the bacterium, while causing cell
injury, is able to down regulate apoptosis. The decrease in apoptosis in
injured gastric cells is one possible mechanism by which this bacterium might
directly increase the susceptibility of gastric cells to carcinogenic
conversion. This grant proposes to evaluate the direct effects of H. pylori on
the cell death in gastric epithelial cells. The Specific Aims of this project
are: 1)To better elucidate the involvement of the p53 pathway in H. pylori
induced apoptosis by determining the extent of phosphorylation of p53 in cells
exposed to H. pylori strains and the importance of phosphorylation at
serine-15,-20 and-46 in regard to apoptosis. Also, to evaluate p53
phosphorylation in response to ROS species in the absence of H. pylori and in
the presence of H. pylori and antioxidants. 2)To determine the involvement and
significance of activation of p53AIPl, which is activated by phosphorylating
p53 at serine-46. The mechnism of bacterial exposure on the gastric epithelial
cell death has not been studied in regard to p53. These studies are important
to elucidate specific p53 pathways that are modulated by exposure to this
bacterium, resulting in an regulating cell death.
Specifically, whether or not stimulation of reactive oxygen species (ROS) by H.
pylori is essential for p53 phosphorylation leading to apoptosis. These studies
will help to establish how bacteria can increase apoptosis possibly through
generation of ROS and in specific circumstances this may alter one's risk of
developing cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inactivation of MSH3 in Colorectal Cancer and Race
-
批准号:10674712
-
项目类别:
-
资助金额:$56.17万
-
财政年份:2021
-
负责人:Hassan Ashktorab
-
依托单位:
Inactivation of MSH3 in Colorectal Cancer and Race
-
批准号:10452491
-
项目类别:
-
资助金额:$11.67万
-
财政年份:2021
-
负责人:Hassan Ashktorab
-
依托单位:
Inactivation of MSH3 in Colorectal Cancer and Race
-
批准号:10187919
-
项目类别:
-
资助金额:$57.95万
-
财政年份:2021
-
负责人:Hassan Ashktorab
-
依托单位:
Inactivation of MSH3 in Colorectal Cancer and Race
-
批准号:10808670
-
项目类别:
-
资助金额:$43.81万
-
财政年份:2021
-
负责人:Hassan Ashktorab
-
依托单位:
MSI
-
批准号:7203720
-
项目类别:
-
资助金额:$4.05万
-
财政年份:2005
-
负责人:Hassan Ashktorab
-
依托单位:
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
-
批准号:7284738
-
项目类别:
-
资助金额:$8.29万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
-
批准号:6942911
-
项目类别:
-
资助金额:$6.55万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
Mechanisms of Growth Inhibition by Helicobacter Pylor
-
批准号:6752694
-
项目类别:
-
资助金额:$5.07万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
-
批准号:7116793
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
-
批准号:6936549
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
-
批准号:6677950
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
-
批准号:6788042
-
项目类别:
-
资助金额:$26.52万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
-
批准号:7283054
-
项目类别:
-
资助金额:$25.15万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
METHYLATION PROFILING AND RISK OF COLORECTAL CANCER
-
批准号:7492504
-
项目类别:
-
资助金额:$8.29万
-
财政年份:2003
-
负责人:Hassan Ashktorab
-
依托单位:
Mechanisms of Growth Inhibition by Helicobacter Pylori
-
批准号:6434556
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2001
-
负责人:Hassan Ashktorab
-
依托单位:
Mechanisms of Growth Inhibition by Helicobacter Pylori
-
批准号:6589502
-
项目类别:
-
资助金额:$7.94万
-
财政年份:2001
-
负责人:Hassan Ashktorab
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: